Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Julphar
Teva
QuintilesIMS
US Army
Moodys
Chinese Patent Office
UBS
Cerilliant
Argus Health

Generated: August 18, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
Abstract:This invention relates to the use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with a retrovirus.
Inventor(s): Lin; Tai-Shun (North Haven, CT), Prusoff; William H. (North Branford, CT)
Assignee: Yale University (New Haven, CT)
Application Number:06/942,666
Patent Claims: 1. A method for treating warm blooded animals infected with a retrovirus, the method comprising administering to the warm blooded animal an anti-retroviral effective amount of 3'-deoxythymidin-2'-ene, either alone or in admixture with a diluent or in the form of a medicament.

2. A method according to claim 1, wherein the retrovirus is Moloney murine leukemia virus.

3. A method according to claim 1, wherein the retrovirus is HTLV III/LAV.

4. A method according to claim 1, wherein the 3'-deoxythymidine-2'-ene is administered intravenously in an amount of 0.01 to 10 mg per kg body weight per day.

5. A method according to claim 1 wherein the 3'-deoxythymidin-2'-ene is in admixture with a solid, liquid or liquified gaseous diluent to form a pharmaceutical composition.

6. A method according to claim 5, wherein the pharmaceutical composition contains 0.5 to 90% of said 3'-deoxythymidin-2'-ene.

7. A method according to claim 5, wherein the pharmaceutical composition is in the form of a sterile physiologically isotonic aqueous solution.

8. A method for treating human blood cells infected with HIV comprising administering to said cells an antiretroviral effective amount of 3'-deoxythymidin-2'-ene either alone or in admixture with a diluent or in the form of a medicament.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Healthtrust
Accenture
US Army
Cerilliant
Fuji
Boehringer Ingelheim
Novartis
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot